Omada Health appoints Dr. Thomas Tsang as Chief Medical Officer to enhance clinical quality and innovation in virtual healthcare.
Quiver AI Summary
Omada Health has appointed Dr. Thomas Tsang, an experienced leader in virtual care and health technology, as its new Chief Medical Officer. Dr. Tsang, who has a background in academia, clinical care, and health policy, will oversee the clinical organization at Omada and focus on enhancing clinical quality and innovation. His previous roles include Chief Strategy Officer at Valera Health, where he helped scale virtual care, and Chief Medical Officer at Merck Healthcare Services. Dr. Tsang's expertise will support Omada's efforts to improve care delivery amidst the growing prevalence of chronic diseases, leveraging technology such as their GLP-1 Care Track and new AI capabilities. Omada Health continues to focus on using evidence-based strategies to enhance member engagement and drive better health outcomes across its extensive client base.
Potential Positives
- Appointment of Dr. Thomas Tsang as Chief Medical Officer brings extensive experience in healthcare delivery and health information technology, which could enhance Omada Health’s clinical outcomes and innovation.
- Dr. Tsang has a strong track record from his previous role at Valera Health, where he scaled virtual specialty care and raised significant funding, indicating potential for growth at Omada.
- Expansion of Omada's GLP-1 Care Track has already served over 100,000 members, demonstrating the effectiveness and reach of their services.
- Omada is strengthening its artificial intelligence capabilities with new tools for personalized nutrition guidance, reflecting a commitment to innovation and improving health outcomes.
Potential Negatives
- Dr. Tsang's appointment highlights the company's need for strong leadership at a strategic moment, which may suggest past challenges in this area.
- While expanding its AI capabilities, Omada may be signaling an underlying necessity to innovate in response to competitive pressures in the digital healthcare space.
- The press release indicates a significant emphasis on chronic disease management, which could reflect concerns about the increasing prevalence of such conditions among their patient population.
FAQ
Who has been appointed as the new Chief Medical Officer at Omada Health?
Thomas Tsang, MD, MPH has been appointed as the Chief Medical Officer of Omada Health.
What previous roles has Dr. Tsang held in healthcare?
Dr. Tsang has served as the Chief Medical Officer at Merck and the founding CEO of Valera Health.
What is Omada Health's focus in healthcare delivery?
Omada Health focuses on virtual care innovations and evidence-based approaches to manage chronic conditions.
How does Omada Health leverage technology in its services?
Omada integrates artificial intelligence into its offerings, such as nutrition education and personalized guidance.
What recognition has Omada Health received for its workplace culture?
Omada Health is certified as a Great Place to Work®, highlighting its vibrant work culture.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$OMDA Hedge Fund Activity
We have seen 2 institutional investors add shares of $OMDA stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CIGNA INVESTMENTS INC /NEW added 3,444,630 shares (+inf%) to their portfolio in Q3 2025, for an estimated $76,160,769
- MASSMUTUAL PRIVATE WEALTH & TRUST, FSB added 9 shares (+inf%) to their portfolio in Q3 2025, for an estimated $198
- LIBERTY STREET ADVISORS, INC. added 0 shares (+0.0%) to their portfolio in Q3 2025, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OMDA Analyst Ratings
Wall Street analysts have issued reports on $OMDA in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 10/22/2025
- Canaccord Genuity issued a "Buy" rating on 08/08/2025
- Needham issued a "Buy" rating on 08/08/2025
- Evercore ISI Group issued a "Outperform" rating on 07/09/2025
- JP Morgan issued a "Overweight" rating on 07/01/2025
- Morgan Stanley issued a "Overweight" rating on 07/01/2025
- Goldman Sachs issued a "Buy" rating on 07/01/2025
To track analyst ratings and price targets for $OMDA, check out Quiver Quantitative's $OMDA forecast page.
$OMDA Price Targets
Multiple analysts have issued price targets for $OMDA recently. We have seen 8 analysts offer price targets for $OMDA in the last 6 months, with a median target of $24.5.
Here are some recent targets:
- Saket Kalia from Barclays set a target price of $28.0 on 10/22/2025
- Vikram Kesavabhotla from Baird set a target price of $24.0 on 09/05/2025
- Ryan MacDonald from Needham set a target price of $24.0 on 08/08/2025
- Richard Close from Canaccord Genuity set a target price of $28.0 on 08/08/2025
- An analyst from Evercore ISI Group set a target price of $23.0 on 07/09/2025
- Destiny Jackson from JP Morgan set a target price of $20.0 on 07/01/2025
- Craig Hettenbach from Morgan Stanley set a target price of $25.0 on 07/01/2025
Full Release
SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced the appointment of Thomas Tsang, MD, MPH as Chief Medical Officer. Dr. Tsang brings extensive experience in academia, clinical care delivery, and health information technology. In this role, he will lead Omada's clinical organization while advancing clinical quality, outcomes, strategy, and innovation across Omada’s multi-condition platform.
"Dr. Tsang's exceptional track record in building a virtual care delivery platform makes him the ideal clinical leader to help drive Omada's next phase of growth," said Sean Duffy, CEO and Co-Founder of Omada Health. "As founding CEO and later Chief Strategy Officer of Valera Health, he successfully scaled virtual specialty care while maintaining clinical excellence and expanding access to underserved populations. His rare combination of hands-on clinical practice, policy expertise, and engagement in the national healthcare quality framework will be instrumental as we work to bend the curve of chronic disease."
Dr. Tsang currently serves on the boards of Blue Cross and Blue Shield of Kansas City and the National Committee for Quality Assurance (NCQA). As founding CEO of Valera Health, he led the company through significant growth, raising over $75 million in funding and scaling to more than 500 employees in five years. Valera, which delivers high-quality behavioral health specialty care for high acuity patients, earned recognition from Digital Health New York 1 and Fast Company 2 for its innovative approach to care delivery.
His earlier experience includes serving as Chief Medical Officer of Merck Healthcare Services and Solutions, a Merck subsidiary focused on digital health solutions. As Medical Director at the Office of the National Coordinator for Health Information Technology under the Obama Administration, he helped shape a national framework for electronic health records to improve care coordination and quality. Dr. Tsang also contributed to the development of the Affordable Care Act while serving as a Robert Wood Johnson Foundation/Institute of Medicine Health Policy Fellow on the U.S. House Ways and Means Committee. Dr. Tsang began his career as Chief Medical Officer of the Charles B. Wang Community Health Center and served on the New York City Board of Health.
"I am thrilled to join Omada Health at this pivotal moment in healthcare delivery," said Dr. Tsang. "As we witness the convergence of virtual care innovation and the growing prevalence of chronic conditions, Omada's evidence-based approach and multi-condition platform are uniquely positioned to improve care delivery. Throughout my career, I've focused on leveraging technology to expand access to high-quality care while maintaining clinical rigor. Omada's vision aligns with this mission, and I look forward to working with the team to advance this important work."
Dr. Tsang's appointment comes at a strategic time for Omada Health as the company strengthens its position in an evolving digital healthcare landscape. The company continues to expand the scale of its GLP-1 Care Track, which has served over 100,000 members since launch. Simultaneously, Omada is expanding its artificial intelligence capabilities, as demonstrated by the recent launch of OmadaSpark for nutrition education and motivational interviewing and Meal Map for personalized nutrition guidance. These focus areas reflect Omada's commitment to combining innovative technology with human-led care to drive member engagement and improved health outcomes.
Omada Health
Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 30 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada’s scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.
The foundation of Omada’s success is a strong, vibrant work culture, which helped earn the company the distinction of becoming an officially certified Great Place to Work ® . An industry leader, Omada was the first virtual provider to join the Institute for Healthcare Improvement’s Leadership Alliance, reflecting the aim to complement primary care providers for the benefit of members, and affirming its guarantee to every partner: Omada works differently.
Great Place to Work ® is the registered trademark of the Great Place to Work Institute and is used under license.
Contacts
Rose Ramseth
[email protected]
Citations
- Digital Health New York. 2025 New York Healthcare Innovation Report. Published February 6, 2025. Accessed October 8, 2025. https://static1.squarespace.com/static/62c854a63c491014a5fa45ce/t/67a50d949c7d7622cefb5d59/1738870165741/DHNY+2025+New+York+Healthcare+Innovation+Report.pdf .
- Valera Health. Valera Health named in Fast Company’s second annual list of Brands That Matter. Published October 26, 2022. Accessed October 8, 2025. https://www.prnewswire.com/news-releases/valera-health-named-in-fast-companys-second-annual-list-of-brands-that-matter-301658596.html